Illumina appoints David P. King to Board as three directors retire ahead of annual meeting

Illumina announced that Frances Arnold, Robert S. Epstein, and Gary S. Guthart will retire from its Board of Directors at the upcoming annual shareholders meeting. The company nominated David P. King to join the Board, bringing his extensive healthcare and life sciences experience. This leadership change aims to support Illumina's next phase of growth and innovation in genomics and healthcare technology. The Board expressed gratitude for the retiring members' contributions during a transformative period for the company.